Cargando…
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review
Taxanes, including paclitaxel and docetaxel, are one of the most active cytotoxic agents in breast cancer treatment including Her-2 positive subtype characterized by aggressive clinical and pathological features since the early stage. However, their use is sometimes limited by the occurrence of hype...
Autores principales: | Pellegrino, Benedetta, Boggiani, Daniela, Tommasi, Chiara, Palli, Dante, Musolino, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142845/ https://www.ncbi.nlm.nih.gov/pubmed/29083340 http://dx.doi.org/10.23750/abm.v%vi%i.6138 |
Ejemplares similares
-
Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
por: de Leon, Maria C.B., et al.
Publicado: (2013) -
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions
por: Maurer, Kathryn, et al.
Publicado: (2017) -
My best choice after a round trip from illness
por: Tommasi, Chiara, et al.
Publicado: (2017) -
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
por: Dranitsaris, George, et al.
Publicado: (2015) -
nab-Paclitaxel for the treatment of pancreatic cancer
por: Kim, George
Publicado: (2017)